Diabetes Drugs Partnering and Deal Making Conference (DDP2011)
|Event Date/Time: Mar 07, 2011||End Date/Time: Mar 08, 2011|
With more than 400 drug candidates for diabetes in active development and in light of the recent US Food and Drug Administration (FDA) guidance to assess cardiovascular risk in clinical trials, the burden to develop novel drugs is greater and the barrier for success has become higher than ever. What will be the next block-buster drug target for T1DM and T2DM? How does the recent FDA guidance affect our approach to develop new medications for diabetes? How do different size companies adapt the best strategy to be competitive in this field?
GTCbioâ€™s Diabetes Drugs Partnering and Deal Making Conference is a partnering and business development conference that gives companies an opportunity to network with high-level executives and explore potential collaborations, learn about relevant issues and deals that will affect the industry. This important meeting will be held on March 7-8, 2011 in Philadelphia, PA. The conference will bring together the leading experts on diabetes from both industry and academia to discuss business strategies and opportunities under the current regulatory landscape.
Session I: Investment Opportunities in Diabetes Drugs
Session II: Innovative Partnering & Licensing Strategies
Session III: Panel Discussion - Investment, Partnership and M&A Deals in Diabetes
Session IV: Clinical Drug Development in Diabetes
Session V: New Therapeutic Targets for Diabetes Cont`d
Session VI: Regulatory Landscape and the Impact on Drug Development and Discovery
2011 Conference Advisory Committee